Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $982000.0.

  • Pulse Biosciences' Non Operating Income rose 71.79% to $982000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 7587.65%. This contributed to the annual value of $2.7 million for FY2024, which is 9589.44% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Non Operating Income is $982000.0, which was up 71.79% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Non Operating Income peaked at $1.2 million during Q1 2025, and registered a low of -$452000.0 during Q4 2022.
  • Moreover, its 5-year median value for Non Operating Income was $410500.0 (2024), whereas its average is $431937.5.
  • In the last 5 years, Pulse Biosciences' Non Operating Income plummeted by 743333.33% in 2022 and then surged by 500000.0% in 2023.
  • Over the past 5 years, Pulse Biosciences' Non Operating Income (Quarter) stood at -$6000.0 in 2021, then crashed by 7433.33% to -$452000.0 in 2022, then skyrocketed by 232.74% to $600000.0 in 2023, then skyrocketed by 46.0% to $876000.0 in 2024, then grew by 12.1% to $982000.0 in 2025.
  • Its Non Operating Income was $982000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $1.2 million in Q1 2025.